Janumet combines the complementary actions of sitagliptin, a DPP-4 inhibitor, and metformin, a biguanide.
Sitagliptin increases glucose-dependent insulin secretion and decreases glucagon production, while metformin reduces hepatic glucose production and improves insulin sensitivity.
Together they provide effective glycaemic control when diet, exercise, or single-agent therapy is insufficient.
Uses
- Type 2 diabetes mellitus
Active Ingredients
- Sitagliptin 50mg
- Metformin Hydrochloride 1000mg
How to Take
- Take with meals exactly as prescribed by your healthcare provider.
Precautions
- Prescription-only medicine.
- Monitor kidney function regularly.
- Be aware of symptoms of pancreatitis and lactic acidosis.
- Regular blood glucose monitoring is recommended.
